These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 18261713)

  • 1. Increased glycogen stores due to gamma-AMPK overexpression protects against ischemia and reperfusion damage.
    Ofir M; Arad M; Porat E; Freimark D; Chepurko Y; Vidne BA; Seidman CE; Seidman JG; Kemp BE; Hochhauser E
    Biochem Pharmacol; 2008 Apr; 75(7):1482-91. PubMed ID: 18261713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A PRKAG2 mutation causes biphasic changes in myocardial AMPK activity and does not protect against ischemia.
    Banerjee SK; Ramani R; Saba S; Rager J; Tian R; Mathier MA; Ahmad F
    Biochem Biophys Res Commun; 2007 Aug; 360(2):381-7. PubMed ID: 17597581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transgenic mice overexpressing mutant PRKAG2 define the cause of Wolff-Parkinson-White syndrome in glycogen storage cardiomyopathy.
    Arad M; Moskowitz IP; Patel VV; Ahmad F; Perez-Atayde AR; Sawyer DB; Walter M; Li GH; Burgon PG; Maguire CT; Stapleton D; Schmitt JP; Guo XX; Pizard A; Kupershmidt S; Roden DM; Berul CI; Seidman CE; Seidman JG
    Circulation; 2003 Jun; 107(22):2850-6. PubMed ID: 12782567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of histidine-rich Ca-binding protein protects against ischemia/reperfusion-induced cardiac injury.
    Zhou X; Fan GC; Ren X; Waggoner JR; Gregory KN; Chen G; Jones WK; Kranias EG
    Cardiovasc Res; 2007 Aug; 75(3):487-97. PubMed ID: 17499229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of MnSOD protects against myocardial ischemia/reperfusion injury in transgenic mice.
    Chen Z; Siu B; Ho YS; Vincent R; Chua CC; Hamdy RC; Chua BH
    J Mol Cell Cardiol; 1998 Nov; 30(11):2281-9. PubMed ID: 9925365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole body heat shock fails to protect mouse heart against ischemia/reperfusion injury: role of 72 kDa heat shock protein and antioxidant enzymes.
    Xi L; Chelliah J; Nayeem MA; Levasseur JE; Hess ML; Kukreja RC
    J Mol Cell Cardiol; 1998 Nov; 30(11):2213-27. PubMed ID: 9925359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute metformin therapy confers cardioprotection against myocardial infarction via AMPK-eNOS-mediated signaling.
    Calvert JW; Gundewar S; Jha S; Greer JJ; Bestermann WH; Tian R; Lefer DJ
    Diabetes; 2008 Mar; 57(3):696-705. PubMed ID: 18083782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preconditioning effects of steroids and hyperoxia on cardiac ischemia-reperfusion injury and vascular reactivity.
    Kaljusto ML; Stensløkken KO; Mori T; Panchenko A; Frantzen ML; Valen G; Vaage J
    Eur J Cardiothorac Surg; 2008 Mar; 33(3):355-63. PubMed ID: 18221880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac-specific overexpression of fibroblast growth factor-2 protects against myocardial dysfunction and infarction in a murine model of low-flow ischemia.
    House SL; Bolte C; Zhou M; Doetschman T; Klevitsky R; Newman G; Schultz Jel J
    Circulation; 2003 Dec; 108(25):3140-8. PubMed ID: 14656920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N488I mutation of the gamma2-subunit results in bidirectional changes in AMP-activated protein kinase activity.
    Zou L; Shen M; Arad M; He H; Løfgren B; Ingwall JS; Seidman CE; Seidman JG; Tian R
    Circ Res; 2005 Aug; 97(4):323-8. PubMed ID: 16051890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AMP-activated protein kinase mediates ischemic glucose uptake and prevents postischemic cardiac dysfunction, apoptosis, and injury.
    Russell RR; Li J; Coven DL; Pypaert M; Zechner C; Palmeri M; Giordano FJ; Mu J; Birnbaum MJ; Young LH
    J Clin Invest; 2004 Aug; 114(4):495-503. PubMed ID: 15314686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transgenic mice overexpressing glutathione peroxidase are resistant to myocardial ischemia reperfusion injury.
    Yoshida T; Watanabe M; Engelman DT; Engelman RM; Schley JA; Maulik N; Ho YS; Oberley TD; Das DK
    J Mol Cell Cardiol; 1996 Aug; 28(8):1759-67. PubMed ID: 8877785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatty acids attenuate insulin regulation of 5'-AMP-activated protein kinase and insulin cardioprotection after ischemia.
    Folmes CD; Clanachan AS; Lopaschuk GD
    Circ Res; 2006 Jul; 99(1):61-8. PubMed ID: 16741157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term caloric restriction improves ischemic tolerance independent of opening of ATP-sensitive K+ channels in both young and aged hearts.
    Shinmura K; Tamaki K; Bolli R
    J Mol Cell Cardiol; 2005 Aug; 39(2):285-96. PubMed ID: 15878170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AMPK control of myocardial fatty acid metabolism fluctuates with the intensity of insulin-deficient diabetes.
    Kewalramani G; An D; Kim MS; Ghosh S; Qi D; Abrahani A; Pulinilkunnil T; Sharma V; Wambolt RB; Allard MF; Innis SM; Rodrigues B
    J Mol Cell Cardiol; 2007 Feb; 42(2):333-42. PubMed ID: 17188707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual cardiac contractile effects of the alpha2-AMPK deletion in low-flow ischemia and reperfusion.
    Carvajal K; Zarrinpashneh E; Szarszoi O; Joubert F; Athea Y; Mateo P; Gillet B; Vaulont S; Viollet B; Bigard X; Bertrand L; Ventura-Clapier R; Hoerter JA
    Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H3136-47. PubMed ID: 17337600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in rat myocardium associated with modulation of ischemic tolerance by diazoxide.
    Simoncíková P; Ravingerová T; Andelová E; Tribulová N; Barancík M
    Gen Physiol Biophys; 2007 Jun; 26(2):75-85. PubMed ID: 17660580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct early signaling events resulting from the expression of the PRKAG2 R302Q mutant of AMPK contribute to increased myocardial glycogen.
    Folmes KD; Chan AY; Koonen DP; Pulinilkunnil TC; Baczkó I; Hunter BE; Thorn S; Allard MF; Roberts R; Gollob MH; Light PE; Dyck JR
    Circ Cardiovasc Genet; 2009 Oct; 2(5):457-66. PubMed ID: 20031621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside increases myocardial glucose uptake during reperfusion and induces late pre-conditioning: potential role of AMP-activated protein kinase.
    Kristiansen SB; Solskov L; Jessen N; Løfgren B; Schmitz O; Nielsen-Kudsk JE; Nielsen TT; Bøtker HE; Lund S
    Basic Clin Pharmacol Toxicol; 2009 Jul; 105(1):10-6. PubMed ID: 19486332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AMP-activated protein kinase: a key stress signaling pathway in the heart.
    Young LH; Li J; Baron SJ; Russell RR
    Trends Cardiovasc Med; 2005 Apr; 15(3):110-8. PubMed ID: 16039971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.